Lam Research Corp のコンセンサス目標株価は $142.4 で、27 人のアナリストの評価に基づいています。最高値は $200(10 23, 2025 に Susquehanna が発表)、最安値は $85(11 29, 2024 に Bernstein が発表)です。直近のアナリスト評価 3 件は Citigroup、UBS、JP Morgan により 11 12, 2025、10 23, 2025、10 23, 2025 に発表されました。Citigroup、UBS、JP Morgan の平均目標株価は $173.33 で、これらの最新評価から Lam Research Corp に対して 16.57% のupsideが示唆されています。
1アナリスト評価から算出
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
11/12/2025 | 27.77% | Citigroup | $175 → $190 | Maintains | Buy | |||
10/23/2025 | 10.96% | UBS | $155 → $165 | Maintains | Buy | |||
10/23/2025 | 10.96% | JP Morgan | $113 → $165 | Maintains | Overweight | |||
10/23/2025 | 34.5% | Susquehanna | $135 → $200 | Maintains | Positive | |||
10/23/2025 | 21.05% | B. Riley Securities | $175 → $180 | Maintains | Buy | |||
10/23/2025 | 14.32% | TD Cowen | $145 → $170 | Maintains | Buy | |||
10/23/2025 | 7.6% | Stifel | $135 → $160 | Maintains | Buy | |||
10/23/2025 | -2.49% | Wells Fargo | $135 → $145 | Maintains | Equal-Weight | |||
10/23/2025 | 34.5% | Oppenheimer | $120 → $200 | Maintains | Outperform | |||
10/23/2025 | 14.32% | Mizuho | $162 → $170 | Maintains | Outperform | |||
10/23/2025 | -7.87% | Morgan Stanley | $125 → $137 | Maintains | Equal-Weight | |||
10/23/2025 | 17.69% | Citigroup | $120 → $175 | Maintains | Buy | |||
10/23/2025 | 7.6% | Needham | $150 → $160 | Maintains | Buy | |||
10/20/2025 | -4.51% | Barclays | $83 → $142 | Maintains | Equal-Weight | |||
10/16/2025 | 8.94% | Mizuho | $130 → $162 | Maintains | Outperform | |||
10/13/2025 | -9.21% | Stifel | $115 → $135 | Maintains | Buy | |||
10/09/2025 | 7.6% | Goldman Sachs | $115 → $160 | Maintains | Buy | |||
09/30/2025 | -14.59% | HSBC | → $127 | Initiates | → Hold | |||
09/29/2025 | 0.87% | Deutsche Bank | $100 → $150 | Upgrade | Hold → Buy | |||
09/24/2025 | 7.6% | B. Riley Securities | $130 → $160 | Maintains | Buy | |||
09/23/2025 | — | Keybanc | — | Downgrade | Overweight → Sector Weight | |||
09/22/2025 | -15.94% | Morgan Stanley | $92 → $125 | Upgrade | Underweight → Equal-Weight | |||
09/12/2025 | -12.58% | Mizuho | $120 → $130 | Maintains | Outperform | |||
09/08/2025 | -19.3% | Citigroup | $113 → $120 | Maintains | Buy | |||
09/02/2025 | -38.13% | Morgan Stanley | $94 → $92 | Downgrade | Equal-Weight → Underweight | |||
08/21/2025 | -19.3% | Cantor Fitzgerald | $115 → $120 | Maintains | Overweight | |||
08/01/2025 | -24.01% | Citigroup | $108 → $113 | Maintains | Buy | |||
08/01/2025 | -19.3% | Argus Research | $105 → $120 | Maintains | Buy | |||
08/01/2025 | -19.3% | Mizuho | $115 → $120 | Maintains | Outperform | |||
07/31/2025 | -34.1% | Wells Fargo | $95 → $98 | Maintains | Equal-Weight | |||
07/31/2025 | -22.66% | Stifel | $110 → $115 | Maintains | Buy | |||
07/31/2025 | -36.79% | Morgan Stanley | $87 → $94 | Maintains | Equal-Weight | |||
07/31/2025 | -26.03% | Raymond James | $90 → $110 | Maintains | Outperform | |||
07/31/2025 | -19.3% | Oppenheimer | $110 → $120 | Maintains | Outperform | |||
07/31/2025 | -22.66% | Needham | $110 → $115 | Maintains | Buy | |||
07/29/2025 | -26.03% | Stifel | $92 → $110 | Maintains | Buy | |||
07/28/2025 | -44.18% | Barclays | $70 → $83 | Maintains | Equal-Weight | |||
07/21/2025 | -19.3% | UBS | $95 → $120 | Maintains | Buy | |||
07/15/2025 | -22.66% | Keybanc | $105 → $115 | Maintains | Overweight | |||
07/14/2025 | -22.66% | Mizuho | $100 → $115 | Maintains | Outperform | |||
07/10/2025 | -22.66% | Goldman Sachs | → $115 | Initiates | → Buy | |||
07/08/2025 | -36.11% | Wells Fargo | $75 → $95 | Maintains | Equal-Weight | |||
07/07/2025 | -27.37% | Citigroup | $87 → $108 | Maintains | Buy | |||
07/01/2025 | -41.49% | Morgan Stanley | $82 → $87 | Maintains | Equal-Weight | |||
06/24/2025 | -22.66% | Cantor Fitzgerald | $90 → $115 | Maintains | Overweight | |||
06/18/2025 | -22.66% | B. Riley Securities | $95 → $115 | Maintains | Buy | |||
06/17/2025 | -26.03% | Oppenheimer | $80 → $110 | Maintains | Outperform | |||
04/24/2025 | -36.11% | UBS | $90 → $95 | Maintains | Buy | |||
04/24/2025 | -36.11% | JP Morgan | $110 → $95 | Maintains | Overweight | |||
04/24/2025 | -39.48% | Raymond James | $100 → $90 | Maintains | Outperform | |||
04/24/2025 | -52.93% | Deutsche Bank | $78 → $70 | Maintains | Hold | |||
04/24/2025 | -36.11% | B. Riley Securities | $90 → $95 | Maintains | Buy | |||
04/24/2025 | -46.2% | Needham | $96 → $80 | Maintains | Buy | |||
04/24/2025 | -44.86% | Morgan Stanley | $81 → $82 | Maintains | Equal-Weight | |||
04/24/2025 | -39.48% | Cantor Fitzgerald | $90 → $90 | Reiterates | Overweight → Overweight | |||
04/24/2025 | -32.75% | TD Securities | $110 → $100 | Maintains | Buy | |||
04/24/2025 | -49.56% | Wells Fargo | $85 → $75 | Maintains | Equal-Weight | |||
04/24/2025 | -33.42% | Evercore ISI Group | $95 → $99 | Maintains | Outperform | |||
04/22/2025 | -52.93% | Barclays | $75 → $70 | Maintains | Equal-Weight | |||
04/16/2025 | -39.48% | B of A Securities | $110 → $90 | Maintains | Buy | |||
04/15/2025 | -38.13% | Stifel | $100 → $92 | Maintains | Buy | |||
04/14/2025 | -39.48% | UBS | $95 → $90 | Maintains | Buy | |||
04/11/2025 | -46.2% | Oppenheimer | $95 → $80 | Maintains | Outperform | |||
03/28/2025 | -32.75% | Jefferies | $95 → $100 | Maintains | Buy | |||
03/20/2025 | -36.11% | Oppenheimer | → $95 | Initiates | → Outperform | |||
02/20/2025 | -29.39% | Keybanc | $95 → $105 | Maintains | Overweight | |||
02/20/2025 | -26.03% | B of A Securities | $100 → $110 | Maintains | Buy | |||
02/20/2025 | -15.94% | Susquehanna | $75 → $125 | Upgrade | Neutral → Positive | |||
02/20/2025 | -32.75% | Mizuho | $87 → $100 | Maintains | Outperform | |||
02/20/2025 | -32.75% | Cantor Fitzgerald | $100 → $100 | Reiterates | Overweight → Overweight | |||
02/18/2025 | -32.75% | Cantor Fitzgerald | $100 → $100 | Maintains | Overweight | |||
01/31/2025 | -47.55% | Deutsche Bank | $76 → $78 | Maintains | Hold | |||
01/30/2025 | -45.53% | Morgan Stanley | $78 → $81 | Maintains | Equal-Weight | |||
01/30/2025 | -41.49% | Mizuho | $90 → $87 | Maintains | Outperform | |||
01/30/2025 | -32.75% | Cantor Fitzgerald | $95 → $100 | Upgrade | Neutral → Overweight | |||
01/30/2025 | -42.84% | Wells Fargo | $82 → $85 | Maintains | Equal-Weight | |||
01/30/2025 | -39.48% | Needham | $90 → $90 | Reiterates | Buy → Buy | |||
01/17/2025 | -36.11% | Keybanc | $95 → $95 | Upgrade | Sector Weight → Overweight | |||
01/17/2025 | -49.56% | Barclays | $90 → $75 | Maintains | Equal-Weight | |||
01/15/2025 | — | Wolfe Research | — | Downgrade | Outperform → Peer Perform | |||
01/13/2025 | -39.48% | Needham | $100 → $90 | Maintains | Buy | |||
01/13/2025 | -44.86% | Wells Fargo | $83 → $82 | Maintains | Equal-Weight | |||
01/10/2025 | -39.48% | Mizuho | $95 → $90 | Maintains | Outperform | |||
01/10/2025 | -42.84% | Goldman Sachs | $96 → $85 | Maintains | Buy | |||
12/06/2024 | -44.18% | Wells Fargo | $85 → $83 | Maintains | Equal-Weight | |||
12/05/2024 | -47.55% | Morgan Stanley | $76 → $78 | Maintains | Equal-Weight | |||
11/29/2024 | -42.84% | Bernstein | $95 → $85 | Maintains | Market Perform | |||
10/24/2024 | -32.75% | Cantor Fitzgerald | $100 → $100 | Reiterates | Neutral → Neutral | |||
10/24/2024 | -48.89% | Morgan Stanley | $77 → $76 | Maintains | Equal-Weight | |||
10/24/2024 | -32.75% | Stifel | $105 → $100 | Reiterates | Buy → Buy | |||
10/24/2024 | -42.84% | Wells Fargo | $88 → $85 | Maintains | Equal-Weight | |||
10/24/2024 | -26.03% | B. Riley Securities | $105 → $110 | Reiterates | Buy → Buy | |||
10/24/2024 | -32.75% | Needham | $100 → $100 | Reiterates | Buy → Buy | |||
10/03/2024 | 491.8% | Wells Fargo | $1000 → $880 | Maintains | Equal-Weight | |||
09/30/2024 | 572.49% | Cantor Fitzgerald | $1200 → $1000 | Maintains | Neutral | |||
09/20/2024 | 538.87% | Mizuho | $1050 → $950 | Maintains | Outperform | |||
09/17/2024 | 420.51% | Morgan Stanley | $929 → $774 | Maintains | Equal-Weight | |||
09/16/2024 | 500.54% | Citigroup | $990 → $893 | Maintains | Buy | |||
09/12/2024 | 673.37% | UBS | $1250 → $1150 | Maintains | Buy | |||
08/05/2024 | 565.77% | Citigroup | $1025 → $990 | Maintains | Buy |
Lam Researchの最新目標株価Lam Research。(NASDAQ:LRCX) の最新目標株価をCitigroupが11 12, 2025日に発表した。このアナリスト会社はLam Research ({{change}:{{mbol}}) {{{quoteName}}の{{change}:{{symbol}}からriseまで12ヶ月以内(27.77% upsideの可能性あり)と予想する$190.00の目標株価を設定しました。過去1年間に87のアナリスト会社がレーティングを報告しています。
Lam Researchの最新のアナリストレーティングはLam Researchです。(NASDAQ:LRCX) の最新のアナリストレーティングはCitigroupによるもので、Lam ResearchのLam Researchです。{actionCompany}}のbuy評価です。
Lam Research Corpの最後のアップグレードは9 29, 2025日に行われ、Deutsche Bankは目標株価を$150に引き上げました。companyName}}のDeutsche Bankの以前のa holdは$150でした。
Lam Research Corpの最後の格下げは9 23, 2025日にKeybancがLam Research Corpの目標株価をN/AからN/Aに変更した時です。
アナリストは、公開財務諸表を調べたり、Lam Researchの役員や顧客に話を聞いたり、決算の電話会議を傍聴したりと、広範な調査を行った上で株価の格付けを行っています。ほとんどのアナリストは3ヶ月ごとにこの作業を行いますので、毎年1社につき4つの格付けを得ることになります。companyName}}の最終レーティングは11 12, 2025日に提出されましたので、次のレーティングは11 12, 2026日あたりに提出されるものと思われます。
レーティングは主観的なものであり変化しますが、最新のLam Research (LRCX) (LRCX) のレーティングは維持で、目標株価は$175.00から$190.00でした。現在の価格 Lam Research ({{exchange}}) (LRCX) の現在の取引価格は$148.70で、これはアナリストの予測レンジout ofです。
ブラウズ アナリスト評価と目標株価 全銘柄の
